BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 16685321)

  • 1. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
    Schacht V; Szeimies RM; Abels C
    Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
    Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
    J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
    de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
    Paech V; Lorenzen T; Stoehr A; Lange K; Merz H; Meigel WN; Plettenberg A
    Eur J Med Res; 2002 Nov; 7(11):477-9. PubMed ID: 12568975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
    Hayami J; Okamoto H; Sugihara A; Horio T
    J Dermatol; 2007 May; 34(5):320-7. PubMed ID: 17408441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Hönigsmann H; Tanew A
    Br J Dermatol; 2005 Feb; 152(2):279-83. PubMed ID: 15727639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
    Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
    J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
    Babilas P; Kohl E; Maisch T; Bäcker H; Gross B; Branzan AL; Bäumler W; Landthaler M; Karrer S; Szeimies RM
    Br J Dermatol; 2006 Apr; 154(4):712-8. PubMed ID: 16536815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Chen HM; Chen CT; Yang H; Kuo MY; Kuo YS; Lan WH; Wang YP; Tsai T; Chiang CP
    Oral Oncol; 2004 Jul; 40(6):630-7. PubMed ID: 15063392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyrin distribution after topical aminolevulinic acid in a novel porcine model of sebaceous skin.
    Sakamoto FH; Tannous Z; Doukas AG; Farinelli WA; Smith NA; Zurakowski D; Anderson RR
    Lasers Surg Med; 2009 Feb; 41(2):154-60. PubMed ID: 19226576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin upregulation by 5-aminolaevulinic acid-based photodynamic therapy in human skin squamous cell carcinoma cell line.
    Kuhara T; Watanabe D; Akita Y; Takeo T; Ishida N; Nakano A; Yamashita N; Ohshima Y; Kawada M; Yanagishita T; Tamada Y; Matsumoto Y
    Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):142-6. PubMed ID: 18477133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
    Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid.
    Calzavara-Pinton PG; Venturini M; Capezzera R; Sala R; Zane C
    Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):144-7. PubMed ID: 15144392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
    Wiegell SR; Stender IM; Na R; Wulf HC
    Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and leucocyte-endothelium interactions contribute to the delayed effects of cryotherapy on tumours in vivo.
    Schacht V; Becker K; Szeimies RM; Abels C
    Arch Dermatol Res; 2002 Nov; 294(8):341-8. PubMed ID: 12420102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.